Rhode Island 2026 Regular Session

Rhode Island House Bill H8172

Introduced
2/27/26  

Caption

Establishes the "Prescription Drug Savings and Transparency Act of 2026."

Impact

The bill is expected to yield substantial benefits, including reduced administrative costs, increased manufacturer rebates returned to Medicaid, and improved access to necessary medications for beneficiaries. The proposed study will assess various management structures, including the current model, which predominantly uses multiple pharmacy benefit managers, as well as alternatives like a single-state preferred drug list or a fee-for-service approach. This could lead to significant changes in how Medicaid prescription drugs are administered, affecting budget allocations and operational efficiencies.

Summary

House Bill 8172, also known as the Prescription Drug Savings and Transparency Act of 2026, aims to enhance the management of prescription drug benefits within the Rhode Island Medicaid program. The legislation is driven by the recognition that prescription drug costs constitute a significant and escalating burden on the state budget, affecting vulnerable populations such as children, seniors, and low-income families. The bill mandates a comprehensive study by the office of the auditor general to evaluate the potential benefits of consolidating prescription drug management, drawing on successful approaches adopted by other states like Kentucky and Connecticut.

Contention

While the bill is positioned as a necessary reform aimed at increasing efficiency and transparency, it may face contention regarding the implications for current contractual relationships with pharmacy benefit managers. Concerns may arise about the extent of oversight and access required by the auditor general to enforce the guidelines and whether this could interfere with established operational practices. Furthermore, as the bill seeks to unify the drug management system under a consolidated approach, local entities may raise questions about potential disruptions to existing services and their ability to meet specific community needs.

Companion Bills

No companion bills found.

Previously Filed As

RI S0117

Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).

RI H5463

Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).

RI S0467

Establishes the Wholesale Prescription Drug Importation Program for the importation of wholesale prescription drugs from Canada, to provide savings to Rhode Island consumers.

RI H5853

Establishes the Wholesale Prescription Drug Importation Program for the importation of wholesale prescription drugs from Canada, to provide savings to Rhode Island consumers.

RI S0221

Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.

RI H5429

Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.

RI H5620

Regulates price increases for prescription drugs.

RI H5116

Directs the state board of pharmacy to annually identify up to fifteen prescription drugs with increased costs and provide the list to the attorney general to obtain reasons for the cost increases.

RI S0121

Requires a report to be produced that focuses on prescription drug prior authorizations by January 1, 2026.

RI H5433

Requires a report to be produced that focuses on prescription drug prior authorizations by January 1, 2026.

Similar Bills

IN SB0140

Pharmacy benefits.

RI S2563

Establishes the "Prescription Drug Savings and Transparency Act of 2026."

FL H0697

Drug Prices and Coverage

NJ S2621

Establishes "Equitable Drug Pricing and Patient Access Act."

NJ A3512

Establishes "Equitable Drug Pricing and Patient Access Act."

AR HB1354

To Regulate Pharmacy Benefits Managers; To Amend The Law Concerning The State And Public School Life And Health Insurance Program; And To Amend The Law Concerning Certain Health Benefit Plans.

NV SB389

Revises provisions relating to the administration of pharmacy benefits under Medicaid and certain other health plans. (BDR 38-240)

HI SB1509

Relating To Prescription Drugs.